Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Trump to impose tariffs of 100% on branded drug imports

(Sharecast News) - Donald Trump is to impose tariffs of 100% on imports of pharmaceutical goods, it emerged on Friday, the latest salvo in the US president's global trade war. Posting on Truth Social, Trump said the levies would be imposed on any branded or patented pharmaceutical product from 1 October.

However, drugs companies could be exempt if they are already building manufacturing facilities in the US.

"There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started," he wrote "Thank you for your attention to this matter!"

A number of pharmaceutical companies worldwide - including AstraZeneca and GSK - have recently announced major US investment plans, in light of long-threatened tariffs on the sector. However, construction may not have started, due to the complex nature of manufacturing across the sector.

The Social Media post was one of several updates on tariffs made by the president early on Friday morning.

He announced a separate 50% tariff on imports of kitchen cabinets and bathroom vanities, also starting from 1 October, and a 30% tax on upholstered furniture.

"The reason for this is the large scale 'FLOODING' of these products into the United States by other outside Countries," he wrote.

In addition, Trump said "all heavy (big!) trucks" made outside of America will be subject to a 25% import charge, to protect US manufacturers from "the onslaught of outside interruptions".

Kathleen Brooks, research director at XTB, said: "This is a reminder that Trump's tariffs are never finished. When we think we can move on from the threat of tariffs, they raise their head once more. The next set of tariffs could be directed at semiconductors and critical rare earth minerals in a number of weeks."

Share this article

Related Sharecast Articles

Funding Circle signs new £700m forward flow deal with Waterfall
(Sharecast News) - SME finance platform Funding Circle has announced a £700m deal with Waterfall Asset Management to provide funding for its shorter-term loan product.
Nuveen's price for Schroders 'too cheap', says Panmure Liberum
(Sharecast News) - Panmure Liberum said on Thursday that US investment manager Nuveen's 612p a share takeover offer for Schroders is "too cheap" and "only a touch ahead of where we might have been pitching a new target price in an independent world".
Magnum Ice Cream results fail to impress as operating profit slides
(Sharecast News) - Shares in Magnum Ice Cream tumbled on Thursday as its first full-year results since the recent demerger from Unilever failed to impress.
THG strikes deal with Greencore to sell protein-enriched convenience foods
(Sharecast News) - THG is to target the booming obesity jab market through a strategic partnership with convenience food producer Greencore Group, it confirmed on Thursday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.